Medline Q2 Earnings Call Highlights
· finance.yahoo.com
Medline (NASDAQ:MDLN) reported second-quarter 2026 net sales growth of 12% to $7.7 billion, supported by demand across its medical-surgical product and supply-chain businesses, while raising its full-year organic sales outlook. The company also lowered its adjusted EBITDA guidance, citing operationa
Medline Brand generated $3.5 billion in second-quarter sales, up 7% from a year earlier. Customer repayments associated with IEEPA tariff refunds reduced segmen...